Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Starting your retirement planning now can lead to a more secure financial future. Discover the reasons to begin your journey today.
27,547 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
GLD's fee drag and tax treatment can erode bullion gains even as gold prices rise. A closer look at cheaper peers and...
Federal investigators have seized over $61 million in USDT linked to romance scam operations, tracing the funds throu...
A fast-moving convergence of quantum computing and robotics is reshaping portfolios. Three ETFs—QTUM, BOTZ, and ROBO—...
A high-stakes cash bid from Merck KGaA sent Bio-Techne stock higher and sparked a flurry of trading. Here’s what inve...
March is on the horizon, and I’m paying close attention to IBM as it heads into a new earnings cycle. The century-old...
A mid-2026 move by a hedge fund to exit EPAM Systems sparked questions about portfolio risk and disclosure. This guid...
UBS researchers say infrastructure stocks have overtaken hyperscalers in AI spending, signaling a shift in AI infrast...
A quick surge in a mining stock can spark headlines and questions. This guide breaks down the what, why, and how to r...
Navitas Semiconductor has ridden a wave of AI infrastructure enthusiasm as data-center spending strengthens. This art...
The era of persistently higher rates is reshaping life insurers' economics. MetLife and Prudential stand to benefit a...
The SEC is moving to settle Justin Sun's case with a $10 million penalty, a move that could reshape crypto enforcemen...